BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 20047501)

  • 1. Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypically unrelated G2P[4] strains in Brazil.
    Correia JB; Patel MM; Nakagomi O; Montenegro FM; Germano EM; Correia NB; Cuevas LE; Parashar UD; Cunliffe NA; Nakagomi T
    J Infect Dis; 2010 Feb; 201(3):363-9. PubMed ID: 20047501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of the monovalent G1P[8] human rotavirus vaccine against hospitalization for severe G2P[4] rotavirus gastroenteritis in Belém, Brazil.
    Justino MC; Linhares AC; Lanzieri TM; Miranda Y; Mascarenhas JD; Abreu E; Guerra SF; Oliveira AS; da Silva VB; Sanchez N; Meyer N; Shafi F; Ortega-Barria E; Soriano-Gabarró M; Colindres RE
    Pediatr Infect Dis J; 2011 May; 30(5):396-401. PubMed ID: 21150692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of rotavirus vaccine against hospitalized rotavirus diarrhea: A case-control study.
    Ichihara MY; Rodrigues LC; Teles Santos CA; Teixeira Mda G; De Jesus SR; Alvim De Matos SM; Gagliardi Leite JP; Barreto ML
    Vaccine; 2014 May; 32(23):2740-7. PubMed ID: 24508336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States.
    Boom JA; Tate JE; Sahni LC; Rench MA; Hull JJ; Gentsch JR; Patel MM; Baker CJ; Parashar UD
    Pediatrics; 2010 Feb; 125(2):e199-207. PubMed ID: 20083525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of Monovalent Rotavirus Vaccine After Programmatic Implementation in Botswana: A Multisite Prospective Case-Control Study.
    Gastañaduy PA; Steenhoff AP; Mokomane M; Esona MD; Bowen MD; Jibril H; Pernica JM; Mazhani L; Smieja M; Tate JE; Parashar UD; Goldfarb DM
    Clin Infect Dis; 2016 May; 62 Suppl 2():S161-7. PubMed ID: 27059351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Live attenuated human rotavirus vaccine, RIX4414, provides clinical protection in infants against rotavirus strains with and without shared G and P genotypes: integrated analysis of randomized controlled trials.
    De Vos B; Han HH; Bouckenooghe A; Debrus S; Gillard P; Ward R; Cheuvart B
    Pediatr Infect Dis J; 2009 Apr; 28(4):261-6. PubMed ID: 19289978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on Rotarix: an oral human rotavirus vaccine.
    O'Ryan M; Linhares AC
    Expert Rev Vaccines; 2009 Dec; 8(12):1627-41. PubMed ID: 19943758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apparent extinction of non-G2 rotavirus strains from circulation in Recife, Brazil, after the introduction of rotavirus vaccine.
    Nakagomi T; Cuevas LE; Gurgel RG; Elrokhsi SH; Belkhir YA; Abugalia M; Dove W; Montenegro FM; Correia JB; Nakagomi O; Cunliffe NA; Hart CA
    Arch Virol; 2008; 153(3):591-3. PubMed ID: 18175037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US Counties, 2006-2009.
    Payne DC; Staat MA; Edwards KM; Szilagyi PG; Weinberg GA; Hall CB; Chappell J; Curns AT; Wikswo M; Tate JE; Lopman BA; Parashar UD;
    Clin Infect Dis; 2011 Aug; 53(3):245-53. PubMed ID: 21705316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rotavirus-associated infantile diarrhea in Uberaba, Minas Gerais, on the wake of the Brazilian vaccination program.
    Domingues AL; Morais AT; Cruz RL; Moreira LP; Gouvêa VS
    J Clin Virol; 2008 Nov; 43(3):298-301. PubMed ID: 18775667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case-control evaluation of the effectiveness of the G1P[8] human rotavirus vaccine during an outbreak of rotavirus G2P[4] infection in central Australia.
    Snelling TL; Andrews RM; Kirkwood CD; Culvenor S; Carapetis JR
    Clin Infect Dis; 2011 Jan; 52(2):191-9. PubMed ID: 21288843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of rotavirus and all-cause diarrhea in northeast Brazil following the introduction of a national vaccination program.
    Gurgel RG; Bohland AK; Vieira SC; Oliveira DM; Fontes PB; Barros VF; Ramos MF; Dove W; Nakagomi T; Nakagomi O; Correia JB; Cunliffe N; Cuevas LE
    Gastroenterology; 2009 Dec; 137(6):1970-5. PubMed ID: 19632228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of Pentavalent Rotavirus Vaccine Against a Diverse Range of Circulating Strains in Nicaragua.
    Patel M; Pedreira C; De Oliveira LH; Tate J; Leshem E; Mercado J; Umaña J; Balmaceda A; Reyes M; Kerin T; McDonald S; Gentsch J; Bowen MD; Parashar U
    Clin Infect Dis; 2016 May; 62 Suppl 2():S127-32. PubMed ID: 27059346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of Monovalent and Pentavalent Rotavirus Vaccines in Guatemala.
    Gastañaduy PA; Contreras-Roldán I; Bernart C; López B; Benoit SR; Xuya M; Muñoz F; Desai R; Quaye O; Tam KI; Evans-Bowen DK; Parashar UD; Patel M; McCracken JP
    Clin Infect Dis; 2016 May; 62 Suppl 2():S121-6. PubMed ID: 27059345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher proportion of G2P[4] rotaviruses in vaccinated hospitalized cases compared with unvaccinated hospitalized cases, despite high vaccine effectiveness against heterotypic G2P[4] rotaviruses.
    Matthijnssens J; Zeller M; Heylen E; De Coster S; Vercauteren J; Braeckman T; Van Herck K; Meyer N; Pirçon JY; Soriano-Gabarro M; Azou M; Capiau H; De Koster J; Maernoudt AS; Raes M; Verdonck L; Verghote M; Vergison A; Van Damme P; Van Ranst M;
    Clin Microbiol Infect; 2014 Oct; 20(10):O702-10. PubMed ID: 24580887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticipating rotavirus vaccines in Brazil: detection and molecular characterization of emerging rotavirus serotypes G8 and G9 among children with diarrhoea in Recife, Brazil.
    Montenegro FM; Correia JB; Rodrigues Falbo A; Dove W; Nakagomi T; Nakagomi O; Cuevas LE; Cunliffe NA; Hart CA
    J Med Virol; 2007 Mar; 79(3):335-40. PubMed ID: 17245712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rotavirus and the indigenous children of the Australian outback: monovalent vaccine effective in a high-burden setting.
    Snelling TL; Schultz R; Graham J; Roseby R; Barnes GL; Andrews RM; Carapetis JR
    Clin Infect Dis; 2009 Aug; 49(3):428-31. PubMed ID: 19566443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case-control study of the effectiveness of vaccination with pentavalent rotavirus vaccine in Nicaragua.
    Mast TC; Khawaja S; Espinoza F; Paniagua M; Del Carmen LP; Cardellino A; Sánchez E
    Pediatr Infect Dis J; 2011 Nov; 30(11):e209-15. PubMed ID: 21768920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A critical review on a globally-licensed, live, orally-administrable, monovalent human rotavirus vaccine: Rotarix.
    Nakagomi T; Nakagomi O
    Expert Opin Biol Ther; 2009 Aug; 9(8):1073-86. PubMed ID: 19591630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Preliminary Assessment of Rotavirus Vaccine Effectiveness in Zambia.
    Beres LK; Tate JE; Njobvu L; Chibwe B; Rudd C; Guffey MB; Stringer JS; Parashar UD; Chilengi R
    Clin Infect Dis; 2016 May; 62 Suppl 2():S175-82. PubMed ID: 27059353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.